Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple other cancer indications AMSTERDAM, (GLOBE NEWSWIRE) -- Avidicure, a biotechnology ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Aion Silicon (formerly Sondrel), a premier ASIC/SoC architecture and design partner, today announced it has joined the Intel Foundry Accelerator Design Services Alliance. This collaboration enhances ...

Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for vision restoration, today announced it has been awarded an $8 million grant from the California Institute for ...

This strategic investment forms part of TDB’s broader vision to advance indigenous, sustainable technologies aligned with ...

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

Q1 2025 Sales/Trading Statement Call April 24, 2025 3:00 AM ET. Company Participants. Fernando Fernandez - Chief Executive Officer Srinivas Phatak - Acting ...

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research April 24th, 2025 Martigny, Switzerland. Dijon, France – Debiopharm Research & ...

During the first quarter of 2025, operating revenue mostly comprised Research Tax Credit of 2.3 million compared to €1.6 million for the same period in 2024. This increase reflects the progress of the ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...